Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Biomerica (BMRA) Operating Expenses (2016 - 2026)

Biomerica's Operating Expenses history spans 17 years, with the latest figure at $1.3 million for Q1 2026.

  • On a quarterly basis, Operating Expenses rose 2.03% to $1.3 million in Q1 2026 year-over-year; TTM through Feb 2026 was $5.5 million, a 5.53% decrease, with the full-year FY2025 number at $5.6 million, down 19.25% from a year prior.
  • Operating Expenses hit $1.3 million in Q1 2026 for Biomerica, down from $1.4 million in the prior quarter.
  • Over the last five years, Operating Expenses for BMRA hit a ceiling of $2.4 million in Q2 2022 and a floor of $1.2 million in Q1 2025.
  • Historically, Operating Expenses has averaged $1.7 million across 5 years, with a median of $1.7 million in 2024.
  • Biggest five-year swings in Operating Expenses: soared 38.83% in 2022 and later crashed 33.6% in 2025.
  • Tracing BMRA's Operating Expenses over 5 years: stood at $2.0 million in 2022, then fell by 4.21% to $1.9 million in 2023, then dropped by 26.02% to $1.4 million in 2024, then decreased by 0.42% to $1.4 million in 2025, then decreased by 11.94% to $1.3 million in 2026.
  • Business Quant data shows Operating Expenses for BMRA at $1.3 million in Q1 2026, $1.4 million in Q4 2025, and $1.5 million in Q3 2025.